News
Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday ...
James Klug on MSN1d
How Democrats Respond to the Economic Impact of Illegal ImmigrationThe cost of illegal immigration is a hot-button issue – and Democrats have a wide range of reactions. In this video, we break down how Democratic leaders and voters are responding to the economic, ...
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...
Ozempic and Wegovy would no longer be covered by the state’s health insurance for low-income people under the governor’s ...
Weight loss drugs like semaglutide could add £4.5 billion to the UK economy annually, boosting productivity and reducing ...
GLP-1 drugs fueled a jump in R.I. health care spending, nearly tripling in three years, report finds
The diabetes and weight loss drugs are “not cost-effective at their current prices, and are largely unavailable to people with lower incomes,” the report said.
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...
The two market veterans dissected President Donald Trump’s latest “reciprocal” tariffs like the seasoned economic surgeons they are.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results